New Two-Pronged attack on type 1 diabetes aims to save Insulin-Producing cells
NCT ID NCT06455319
Summary
This study is testing whether two different drugs can help preserve the body's own insulin production in adolescents and young adults recently diagnosed with type 1 diabetes. Researchers will first use a test to predict who might respond best to an immune-suppressing drug (ATG). Then, they will test if adding a second drug (verapamil) provides extra benefit. The goal is to slow down the disease by protecting the pancreas cells that make insulin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barbara Davis Center for Diabetes
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Florida
RECRUITINGGainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.